100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100030 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100060 - Statement - Condensed Consolidated Statements of Changes in Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100070 - Statement - Condensed Consolidated Statement of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100080 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 100090 - Disclosure - Collaboration Agreements, License Agreement and Revenues link:presentationLink link:calculationLink link:definitionLink 100100 - Disclosure - Variable Interest Entity link:presentationLink link:calculationLink link:definitionLink 100110 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 100120 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 100130 - Disclosure - Balance Sheet Components link:presentationLink link:calculationLink link:definitionLink 100140 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 100150 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 100160 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 100170 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 100180 - Disclosure - Subsequent Event link:presentationLink link:calculationLink link:definitionLink 100190 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 100200 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 100210 - Disclosure - Collaboration Agreements, License Agreement and Revenues (Tables) link:presentationLink link:calculationLink link:definitionLink 100220 - Disclosure - Variable Interest Entity (Tables) link:presentationLink link:calculationLink link:definitionLink 100230 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 100240 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 100250 - Disclosure - Balance Sheet Components (Tables) link:presentationLink link:calculationLink link:definitionLink 100260 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 100270 - Disclosure - Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100280 - Disclosure - Significant Accounting Policies - Summary of Reconciliation of Basic and Diluted Net Income (Loss) Per Share Calculation (Detail) link:presentationLink link:calculationLink link:definitionLink 100290 - Disclosure - Significant Accounting Policies - Schedule of Weighted Impacts of Outstanding Anti-dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share (Detail) link:presentationLink link:calculationLink link:definitionLink 100300 - Disclosure - Collaboration Agreements, License Agreement and Revenues - Astellas Agreements - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100310 - Disclosure - Collaboration Agreements, License Agreement and Revenues - AstraZeneca Agreements - Additional Information 1 (Detail) link:presentationLink link:calculationLink link:definitionLink 100320 - Disclosure - Collaboration Agreements, License Agreement and Revenues - Summary of License Revenue and Development Revenue Recognized under Agreement (Detail) link:presentationLink link:calculationLink link:definitionLink 100330 - Disclosure - Collaboration Agreements, License Agreement and Revenues - Transaction Price Related to Consideration Received and Accounts Receivable Allocated to Performance Obligations along with Associated Deferred Revenue (Detail) link:presentationLink link:calculationLink link:definitionLink 100340 - Disclosure - Collaboration Agreements, License Agreement and Revenues - Summary of Revenue Recognized Under the Collaboration Agreements - Additional Information 4 (Detail) link:presentationLink link:calculationLink link:definitionLink 100350 - Disclosure - Collaboration Agreements, License Agreement and Revenues - Transaction Price Related to Consideration Received and Accounts Receivable Allocated to Performance Obligations Deferred Revenue (Parenthetical) (Detail) link:presentationLink link:calculationLink link:definitionLink 100360 - Disclosure - Collaboration Agreements, License Agreement and Revenues - Summary of Product Revenue, Net (Detail) link:presentationLink link:calculationLink link:definitionLink 100370 - Disclosure - Collaboration Agreements, License Agreement and Revenues - Product Revenue, Net - Additional Information 1 (Detail) link:presentationLink link:calculationLink link:definitionLink 100380 - Disclosure - Collaboration Agreements, License Agreement and Revenues - Roll-forward of Related Contract Liabilities (Detail) link:presentationLink link:calculationLink link:definitionLink 100390 - Disclosure - Collaboration Agreements, License Agreement and Revenues - Deferred Revenue - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100400 - Disclosure - Collaboration Agreements, License Agreement and Revenues - Drug Product Revenue - Summary of Drug Product Revenue (Detail) link:presentationLink link:calculationLink link:definitionLink 100410 - Disclosure - Collaboration Agreements, License Agreement and Revenues - Drug Product Revenue - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100420 - Disclosure - Collaboration Agreements, License Agreement and Revenues - Eluminex Agreement - Additional Information 2 (Detail) link:presentationLink link:calculationLink link:definitionLink 100430 - Disclosure - Collaboration Agreements, License Agreement and Revenues - Summary of Amounts Recognized as Revenue (Detail) link:presentationLink link:calculationLink link:definitionLink 100440 - Disclosure - Variable Interest Entity - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100450 - Disclosure - Variable Interest Entity - Summary of Equity Method Investment (Detail) link:presentationLink link:calculationLink link:definitionLink 100460 - Disclosure - Fair Value Measurements - Fair Values of Financial Assets Measured on Recurring Basis (Detail) link:presentationLink link:calculationLink link:definitionLink 100470 - Disclosure - Fair Value Measurements - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100480 - Disclosure - Balance Sheet Components - Schedule of Cash and Cash Equivalents (Detail) link:presentationLink link:calculationLink link:definitionLink 100490 - Disclosure - Balance Sheet Components - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100500 - Disclosure - Balance Sheet Components - Summary of Amortized Cost, Gross Unrealized Holding Gains or Losses, and Fair Value of Available-for-Sale Investments (Detail) link:presentationLink link:calculationLink link:definitionLink 100510 - Disclosure - Balance Sheet Components - Summary of Available for Sale Securities in Unrealized Loss Position, Fair Value and Gross Unrealized Loss By Length of Time Security in Continual Unrealized Loss Position (Detail) link:presentationLink link:calculationLink link:definitionLink 100520 - Disclosure - Balance Sheet Components - Schedule of Inventory (Detail) link:presentationLink link:calculationLink link:definitionLink 100530 - Disclosure - Balance Sheet Components - Schedule of Accrued and Other Current Liabilities (Detail) link:presentationLink link:calculationLink link:definitionLink 100540 - Disclosure - Stock-Based Compensation - Schedule of Recorded Stock-Based Compensation Expense (Detail) link:presentationLink link:calculationLink link:definitionLink 100550 - Disclosure - Stock-Based Compensation - Schedule of Assumptions used to Estimate Fair Value of Stock Options Granted and Purchases under 2014 Employee Share Purchase Plan (Detail) link:presentationLink link:calculationLink link:definitionLink 100560 - Disclosure - Related Party Transactions - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100570 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100580 - Disclosure - Subsequent Event - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink